帕那利单抗
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
CAS2329669-78-3
Storage condition -80°C for one-year storage.Avoid repeated freeze-thaw.
Security information
Product details

Bavunalimab is a bispecific human monoclonal antibody targeting CTLA-4 and LAG-3, it activates T cells in NSG mice. Bavunalimab can be used for the research of cancer.

Related literature
Related
Sorry, no related items
History
Ranibizumab (Anti-VEGFA)
Siplizumab (Synonyms: MEDI-507)
Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab; AMG 910; )
Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab;XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)
Bimagrumab (Synonyms: Anti-ACVR2B Reference Antibody; BYM338)
Gatipotuzumab | PankoMab
ABX-IL8
Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody)
Anti-Human BCMA Monoclonal Antibody(Belantamab biosimilar) mAb; GSK2857914